$54.05−$2.97 (-5.21%)as of market close, Jul 24, 2026
MRNA — Moderna Inc. stock price, chart and key statistics
Key stats
Price data
- Price
- $54.05
- Change YTD
- +75.15%
- Next earnings
- Jul 31, 2026 · Before open
- Market cap
- 21.4B
- Enterprise value
- 20.1B
- Shares outstanding
- 396.8M
- 52W low
- $22.28
- 52W high
- $85.60
- From 52W high
- -36.86%
- From 52W low
- +142.59%
- 52W range
- 50%
- Beta
- 0.94
Volume
- Rel volume
- 0.91×
- 30D volume
- 8.2M
- 30D $ vol
- 539.9M
Fundamentals
- Sales (ttm)
- 2.2B
- Sales/share
- $5.61
- EPS (ttm)
- -$8.09
- FCF (ttm)
- -1.6B
- FCF/share
- $-4.04
- Book value/share
- $18.67
- Net margin
- -143.55%
- ROE
- -43.12%
- ROA
- -27.80%
- Debt / equity
- 0.08×
- Current ratio
- 2.41
Growth (CAGR, ttm) · 10Y
- Sales
- n/a
- Net income
- n/a
- FCF
- n/a
- Shares
- n/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- n/a
- FCF/share
- n/a
- Book value/share
- n/a
- Price
- n/a
- Total return
- n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- Fwd P/E
- -13.7×
- P/S (ttm)
- 9.6×
- P/B (mrq)
- 2.9×
- EV/Sales (ttm)
- 9.0×
- FCF yield (ttm)
- -7.47%
- Buyback yield (ttm)
- 0.01%
- Shareholder yield (ttm)
- 0.01%
Vs own 10Y history
- P/S
- 57th
- P/B
- 38th
Bar = where today's multiple sits in MRNA's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
-5.21%
1W
-12.57%
1M
-10.54%
3M
+2.27%
YTD
+75.15%
1Y
+55.90%
5Y
-81.13%
Financial statements
Open full MRNA financials →Related Healthcare
1MModerna Inc. (MRNA) trades at $54.05 with a live price and an interactive chart covering 7+ years of daily price history, plus key valuation metrics. ChartRow also publishes MRNA's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full MRNA financial statements →